ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد

Physiologic effects of inhaled cannabis

Physiologic effects of inhaled cannabis
System Acute Chronic
Cardiovascular
  • Naive users at low dose increased HR, increased systolic and diastolic blood pressures, followed by parasympathetic response (bradycardia and hypotension); acute use may result in increased CO
  • Naive users at high dose parasympathetic response may predominate with bradycardia and postural hypotension
  • Various arrhythmias associated with acute use (atrial fibrillation/flutter and ventricular tachycardia/fibrillation)
  • Increased risk of myocardial infarction
  • Increased HR and CO with heavy daily cannabis use
  • High-dose THC can also result in decreased HR and tolerance to orthostatic hypotension
Vascular
  • Variable effects depending on neuronal activity
  • Endothelial vasodilation can increase CBF
  • Hypoxia or hypercapnia may reduce CBF
  • Increased incidence of CVA and TIA related to cerebral vasospasm and atherosclerosis
Respiratory
  • Bronchodilation related to THC-mediated effects
  • Airway hyperreactivity related to local irritation by cannabis smoke
  • Case report of pharyngeal, uvular edema
  • Chronic bronchitis (coughing, increased sputum, and wheezing)
  • Increases in lung volumes
Hematological
  • Variable effects
  • Anticoagulant effects increased clotting times (animal models) and decreased platelet function (human studies)
  • Procoagulant effects increased platelet aggregation and arterial wall inflammation
  • Final effect on hemostasis depends on particular cannabinoids involved and interaction with platelets, endothelial system
Gastrointestinal
  • Antiemetic effects
  • Reduced gastric acid secretion/emptying
  • Reduced GI transit, colonic emptying
  • Increased appetite
  • CHS abdominal pain, nausea, and vomiting
CNS
  • Impaired executive functioning (decision-making, reasoning, and problem-solving)
  • Sedation, dizziness, euphoria, and disorientation
  • Anxiety paranoia and dysphoria
  • Dependence
  • Psychosis
  • Lasting impairments in memory and attention
Endocrine
  • Suppressed secretion of prolactin, growth hormone, and androgen
  • Appetite stimulation
  • Increased energy intake and storage adipogenesis, growth/ intolerance maturation of adipocytes, and increased glucose uptake
  • Decreased gonadal function (males impaired sperm function and gynecomastia; females anovulation and galactorrhea)
  • Reduced insulin secretion and glucose
Thermoregulation
  • Hypothermia
 
CBF: cerebral blood flow; CHS: cannabinoid hyperemesis syndrome; CNS: central nervous system; CO: cardiac output; CVA: cerebrovascular accident; GI: gastrointestinal; HR: heart rate; THC: tretrahydrocannabinol; TIA: transient ischemic attack.
Reproduced with permission from Wolters Kluwer Health, Inc.: Lee BH, Sideries A, Ladha K, et al. Cannabis and cannabinoids in the perioperative period. Anesth Analg 2024;138(1):16-30. Copyright © 2024 International Anesthesia Research Society. https://journals.lww.com/anesthesia-analgesia/pages/default.aspx.
Graphic 146130 Version 2.0